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Abstract
 
At least two types of interleukin (IL)-15 mRNA isoforms are generated by alternative splicing at
the 5
 
9 
 
upstream of exon 5 in mice. To elucidate the potential roles of IL-15 isoforms in immune
responses in vivo, we constructed two groups of transgenic mice using originally described IL-15
cDNA with a normal exon 5 (normal IL-15 transgenic [Tg] mice) and IL-15 cDNA with an al-
ternative exon 5 (alternative IL-15 Tg mice) under the control of an MHC class I promoter.
Normal IL-15 Tg mice constitutionally produced a significant level of IL-15 protein and had
markedly increased numbers of memory type (CD44
 
high
 
 Ly6C
 
1
 
) of CD8
 
1 
 
T cells in the LN.
These mice showed resistance to 
 
Salmonella
 
 infection accompanied by the enhanced interferon
(IFN)-
 
g
 
 production, but depletion of CD8
 
1 
 
T cells exaggerated the bacterial growth, suggesting
that the IL-15–dependent CD8
 
1 
 
T cells with a memory phenotype may serve to protect against
 
Salmonella
 
 infection in normal IL-15 Tg mice. On the other hand, a large amount of intracellu-
lar IL-15 protein was detected but hardly secreted extracellularly in alternative IL-15 Tg mice.
Although most of the T cells developed normally in the alternative IL-15 Tg mice, they showed
impaired IFN-
 
g
 
 production upon TCR engagement. The alternative IL-15 transgenic mice
were susceptible to 
 
Salmonella 
 
accompanied by impaired production of endogenous IL-15 and
IFN-
 
g
 
. Thus, two groups of IL-15 Tg mice may provide information concerning the different
roles of IL-15 isoforms in the immune system in vivo.
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Introduction
 
IL-15 uses 
 
b
 
- and 
 
g
 
-chains of the IL-2R for signal trans-
duction, and thus shares many properties of IL-2 in spite of
having no sequence homology with IL-2 (1–3). IL-15 is
produced by a wide variety of tissues, including placenta,
skeletal muscle, kidney, and activated monocytes/macro-
 
phages, whereas IL-2 is exclusively produced by activated
T cells (4, 5). It has been reported that IL-15 prevents apop-
tosis of lymphocytes in peripheral tissues induced by growth
factor deprivation via upregulation of antiapoptosis proteins,
including Bcl-2 and Bcl-XL (6–8). Mice lacking interferon
regulatory factor-1 (IRF-1
 
2
 
/
 
2
 
 mice)
 
 
 
have an impairment in
IL-15 mRNA expression in bone marrow cells and exhibit
a severe deficiency of NK cells and NK1.1
 
1 
 
T cells (9, 10).
Recently, Lodelce et al. (11) showed that IL-15R
 
a
 
2
 
/
 
2
 
mice are deficient in NK cells, NK1.1
 
1 
 
T cells, memory
phenotype of CD8
 
1 
 
T cells, and TCR-
 
g
 
/
 
d
 
 intraepithelial
lymphocytes. It thus appears that IL-15 has potential roles in
the development and maintenance of significant fractions
of lymphocytes.
IL-15 has also been shown to stimulate macrophages (12),
mast cells (13), NK cells (14), T cells (4) and B cells (15) to
proliferate, secrete cytokines, exhibit increased cytotoxicities
and/or produce Ab, and it is thus involved in protection
 
Address correspondence to Hitoshi Nishimura, Laboratory of Host
Defense & Germfree Life, Research Institute for Disease Mechanism and
Control, Nagoya University School of Medicine, Nagoya 466-8550,
Japan. Phone:
 
 
 
81-52-744-2447; Fax: 81-52-744-2449; E-mail: nishihit
@med.nagoya-u.ac.jp 
158
 
Differential Roles of IL-15 mRNA Isoforms in Immune Responses
 
against infection with 
 
Toxoplasma gondii 
 
(16),
 
 Cryptococcus neo-
formans 
 
(17),
 
 Candida albicans 
 
(18),
 
 Salmonella
 
 
 
choleraesuis
 
 (19),
 
Escherichia coli 
 
(20),
 
 Listeria monocytogenes 
 
(21), 
 
Mycobacterium
tuberculosis
 
, 
 
Mycobacterium leprae
 
,
 
 
 
Bacillus Calmette-Guerin
(22, 23), human immunodeficiency virus (24), human herpes
virus-6 (25), -7 (26), or hepatitis C virus (27), and in the
pathogenesis of autoimmune diseases such as rheumatoid ar-
thritis (28, 29) and inflammatory bowel disease (30, 31). Fur-
thermore, several reports have suggested that IL-15 has anti-
tumor effects (32, 33). Thus, IL-15 may play pleiotropic
roles in immune responses in infection, tumor, allergy, and
autoimmune diseases.
IL-15 translation and secretion are impeded by multiple
control elements, including upstream AUGs of 5
 
9 
 
UTR
(5, 34), unusual signal peptides (34–37), and the COOH
terminus of the mature protein (38). Hence, it has been diffi-
cult to demonstrate IL-15 protein in the supernatants of var-
ious cells/tissues that express messages for this cytokine. We
have previously cloned several isoforms of IL-15 mRNA
generated by alternative splicing in mice (34). One of these
isoforms, which had an alternative exon 5 containing another
3
 
9
 
 splicing site, exhibited a high translational efficiency as
compared with other isoforms with the originally described
exon 5, which is generated by internal splicing of the alter-
native exon 5. The translation product of the alternative
isoform lacks hydrophobic domains of the signal sequence
in the leader peptide, suggesting that the IL-15 protein de-
rived from this isoform is located intracellularly, whereas
the product encoded by the IL-15 mRNA with the normal
exon 5 may be released extracellularly.
In the present study, to elucidate the potential roles of
IL-15 encoded by mRNA isoforms in immune responses in
vivo, we constructed two groups of transgenic (Tg)
 
1
 
 mice
using two isoforms of IL-15 cDNA with a normal exon 5 or
alternative exon 5 under the control of an MHC class I pro-
moter. We found that normal IL-15 Tg mice constitutively
produced a significant level of IL-15 protein, whereas a large
amount of intracellular IL-15 protein was detected but little
was secreted extracellularly in alternative IL-15 Tg mice.
Memory type (CD44
 
high
 
 Ly6C
 
1
 
) of CD8
 
1 
 
T cells were
markedly increased in the lymph node of normal IL-15 Tg
mice, whereas the numbers of NK1.1
 
1 
 
T cells or NK cells
were reduced in alternative IL-15 Tg mice. Normal IL-15
Tg mice showed resistance to 
 
Salmonella 
 
infection accompa-
nied by enhanced IFN-
 
g
 
 production, while alternative IL-15
transgenic mice were susceptible to the infection accompa-
nied by impaired production of endogenous IL-15 and
IFN-
 
g
 
. The implications of these findings for differential
roles of IL-15 mRNA isoforms in vivo are discussed.
 
Materials and Methods
 
Transgene Construction and Generation of Transgenic Mice.
 
Full-
length cDNA encoding the murine IL-15 gene with the origi-
nally described exon 5 (710 bp) (39) or alternative exon 5 (830
 
bp) (34) was cloned between the BamHI and SalI sites of a trans-
genic expression vector, pHSE-3
 
9
 
, which contains the H-2K pro-
moter and Ig enhancer, and 
 
b
 
-globin splice site and poly A signal.
Transgene DNAs were microinjected into the male pronucleus of
fertilized single-cell embryos of C57BL/6 mice. Microinjected
eggs were transferred to pseudopregnant C57BL/6 foster moth-
ers. IL-15 Tg mice were identified by digesting genomic DNA
with PstI, followed by Southern blot analysis using an IL-15–spe-
cific probe. In each experiment, age- and sex-matched littermates
were used. C57BL/6 mice were obtained from Japan SLC. Mice
were maintained under specific pathogen-free conditions and offered
food and water ad libitum. All mice were used at 6–8 wk of age.
 
Competitive Reverse Transcription PCR.
 
mRNA was prepared
from the peritoneal macrophages of wild-type or IL-15 Tg mice
using a QuickPrep Micro mRNA Purification Kit (Pharmacia
LKB Biotechnology, Inc.). First-strand cDNA was synthesized
from 2 
 
m
 
g mRNA using reverse transcriptase (SuperScript II RT;
Life Technologies, Inc.) and 20 pmol of random primer in 20 
 
m
 
l
reaction mixtures, according to the manufacturer’s instructions.
The synthesized first-strand cDNA (2 
 
m
 
l) was amplified by means
of the PCR using 20 pmol of each primer specific for murine
 
b
 
-actin or IL-15 with 2.5 U rTaq (Takara Shuzou) in a total
volume of 50 
 
m
 
l reaction buffer consisting of 10 mM Tris-HCl,
pH 8.3, 50 mM KCl, 1.5 mM MgCl
 
2
 
, 0.001% gelatin, and 0.2
 
m
 
M dNTP. The specific primers were as follows: 
 
b
 
-actin sense,
5
 
9
 
-TTCTGCATCCTGTCAGCAAT-3
 
9
 
; antisense, 5
 
9
 
-TAAAA-
CGCAGCTCAGTAACAGTCCG-3
 
9
 
; IL-15 exons 6 and 7 sense,
5
 
9
 
-GTGATGTTCACCCCAGTTGC-3
 
9
 
; and IL-15 exon 8 anti-
sense, 5
 
9
 
-TCACATTCTTTGCATCCAGA-3
 
9
 
. The cDNA was
coamplified with a known amount of specific competitor “mimic”
fragment. The cDNA was coamplified in a series of three reac-
tions with a twofold dilution series of mimic concentrations. The
products were separated on 1% agarose gels.
To estimate the mRNA expression derived from the transgene
in macrophages of alternative IL-15 Tg mice, we amplified the
cDNA from the peritoneal macrophages by RT-PCR with spe-
cific primers for exons 1 and 8, and the amplified products were
hybridized with an internal specific probe for the isoform with an
alternative exon 5. The specific primers were as follows: IL-15
exon 1 sense, 5
 
9
 
-GCTGTGTTTGGAAGGCTGAGTT-3
 
9
 
; and
IL-15 exon 8 antisense, 5
 
9
 
-ATGGAGCTGTGCTGCCTCT-3
 
9
 
.
The PCR products was resolved by electrophoresis on a 1.8%
agarose gel and transferred to a GeneScreen plus filter (NEN Re-
search Products), and then hybridized with a 
 
32
 
P-labeled oligo
probe as follows: IL-15 exon 7, 5
 
9
 
-GCAATGAACTGCTTT-
CTCCTG-3
 
9
 
 (39); and IL-15 additional sequence 
 
f
 
 probe,
5
 
9
 
-AAGCAACGGAACAATCAAGA-3
 
9
 
 (37).
 
Immunofluorescence Staining of Intracellular IL-15 Protein.
 
Peri-
toneal macrophages of IL-15 Tg or control mice were cultured
on coverslips. The cells were fixed in cold acetone. Coverslips
were then incubated with a solution of 5% newborn calf serum in
HBSS (blocking solution) for 1 h at room temperature to reduce
background levels. The cells were incubated with rat anti–murine
IL-15 Ab diluted 1:10 in blocking solution for 2 h at room tem-
perature, washed in excess PBS, and then incubated with a 1:50
dilution of FITC-conjugated goat anti–rat Ig (TAGO Inc.) in
blocking solution for 1 h at room temperature. Anti–murine IL-15
sera were produced in F344 rats by immunization with an emul-
sion containing 
 
z
 
0.2 mg 
 
Escherichia coli–
 
expressed murine IL-15
protein in the form of an insoluble inclusion body preparation in
CFA (Difco Laboratories Inc.). A total of three booster injections
was given, each at 2-wk intervals after primary injection. 2 wk af-
ter the last immunization, we collected blood from the heart.
 
1
 
Abbreviations used in this paper:
 
 HKS, heat killed-
 
Salmonella
 
; MMC, myto-
mycin-C; Tg, transgenic. 
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Fluorescent images were viewed and recorded with an MRC-
series confocal imaging system (Bio-Rad Laboratories).
 
Antibodies and Reagents.
 
Phycoerythrin-conjugated anti–TCR
 
gd
 
 (UC7-13D5), anti–TCR 
 
b
 
 (H57-597), anti–CD4 (GK1.5),
and anti–CD44 (IM7); FITC-conjugated anti–CD3 (145-2C11),
anti–CD8 (53-6.7), anti–CD24 (M1/69), anti–CD44 (IM7), anti–
CD45RB (16A), anti–CD62L (MEL-14), anti–Ly6C (AL-21), anti–
IL-2R
 
a
 
 (7D4), anti–IL-2R
 
b
 
 (TM-
 
b
 
1), anti–IL-2R
 
g
 
 (TUGm3),
and anti–IFN-
 
g
 
 (XMG1.2); and biotin-conjugated anti–NK1.1
mAb (PK136) were purchased from PharMingen. Cy-Chrome–
conjugated streptavidin was obtained from PharMingen. Anti–
TCR 
 
ab
 
 mAb (H57-597) was a gift from Dr. R. Kubo (National
Jewish Center for Immunology and Respiratory Medicine, Den-
ver, CO). Anti–CD3 mAb (145-2C11) was a gift from Dr. J.A.
Bluestone (University of Chicago, Chicago, IL). Purified anti–
murine IL-15 mAb (rat IgG1, G277-3588) and biotin-conjugated
anti–murine IL-15 mAb (rat IgG1, G277-3960) were purchased
from PharMingen.
 
Flow Cytometric Analysis. 
 
The cells were stained with PE-,
FITC-, and biotin-conjugated mAbs. To block FcR-mediated
binding of the mAb, 2.4G2 (anti–Fc
 
g
 
R mAb) was added. All in-
cubation steps were performed at 4
 
8
 
C for 30 min. To detect
biotin-conjugated mAb, cells were stained with Cy-Chrome–
conjugated streptavidin after incubation with a primary mAb.
The stained cells were analyzed by a FACSCalibur
 
®
 
 flow cytom-
eter (Becton Dickinson & Co.). Small lymphocytes were gated
by forward and side scatter.
 
Cell Culture. 
 
Lymphocytes from the LN were cultured in
200 
 
m
 
l of complete culture medium in a 96-well flat-bottom
plate (Falcon Labware, Becton Dickinson & Co.) at a density of
5 
 
3
 
 10
 
5
 
 cells/well with anti–TCR
 
ab mAb (100 mg/ml) that had
been immobilized on the plates by earlier incubation for 1 h. To
estimate cytokine production, the supernatant was collected at
indicated times.
Cytokine Enzyme-linked Immunosorbent Assay. The cytokine
activity in the culture supernatants or serum from the mice was
assayed using a DuoSet ELISA development system (Genzyme
Diagnostics) for IL-4 or IFN-g. ELISA for mouse IL-15 was per-
formed in triplicate using purified anti–mouse IL-15 mAb (capture
mAb, G277-3588; PharMingen), biotin-conjugated anti–mouse
IL-15 mAb (second mAb, G277-3960; PharMingen), and perox-
idase-conjugated streptavidin (detection reagent; Genzyme Corp.).
Analysis of Intracellular Cytokine Synthesis.  C57BL/6 mice or
IL-15 transgenic mice were injected intravenously with 4 mg of
anti–CD3 mAb (145-2C11). After 90 min, the spleen cells were
harvested, washed, and suspended at 106 cells/ml in complete
culture medium, and then incubated for 3 h at 378C in the pres-
ence of 10 mg/ml Brefeldin A (Sigma Chemical Co.). These cells
were harvested, washed, and incubated for 30 min at 48C with
PE-conjugated anti–CD44 mAb, biotin-conjugated CD8 mAb,
and then Cy-Chrome–conjugated streptavidin. After surface stain-
ing, cells were subjected to intracellular cytokine staining using the
Fast Immune Cytokine System according to the manufacturer’s
instructions (Becton Dickinson & Co.). The cells were washed
and fixed in 100 ml of FACS® lysing solution (Becton Dickinson &
Co.) for 15 min at room temperature, and then washed again,
and resuspended in 50 ml of FACS® permeabilizing solution
(Becton Dickinson & Co.) and incubated for 15 min at room tem-
perature. After washing, the cells were stained with FITC-conju-
gated IFN-g mAb or FITC-conjugated isotype control rat IgG
(PharMingen) for 30 min at room temperature and the fluores-
cence of the cells was analyzed by a flow cytometer.
Experiments of Salmonella Infection.  Salmonella subspecies chol-
eraesuis serovar Choleraesuis strain 31N-1 (40) was maintained by
several passages through C57BL/6 mice. The approximate LD50
was 2 3 107 CFU in C57BL/6 mice inoculated intraperitoneally.
Heat-killed Salmonella (HKS) was prepared by incubating viable
S. choleraesuis at 748C for 120 min. Mice were inoculated intra-
peritoneally with 2 3 106 viable S. choleraesuis in 0.2 ml PBS. On
day 6 after inoculation, mice were anesthetized with ether and
killed by cutting their cervical arteries. Peritoneal contents were
lavaged with 5 ml of PBS and harvested after gentle massage.
Samples were serially diluted with PBS. The organ was homoge-
nized thoroughly, and the homogenates were serially diluted with
PBS. Samples were spread on tripto-soya agar (Nissui Pharmaceuti-
cal) plates, and colonies were counted after incubation for 24 h at
378C. Peritoneal exudate cells were prepared by centrifuging peri-
toneal exudates at 110 g for 10 min and suspended at a concentra-
tion of 106 cells/ml in RPMI 1640 containing 10% FCS, 100 U/ml
penicillin, 100 mg/ml of streptomycin, and 10 mM HEPES. Cells
were plated in the wells of 100-mm tissue culture dishes (Nunc,
Inc.) and allowed to adhere for 1 h at 378C in a humidified atmo-
sphere of 95% air and 5% CO2. Nonadherent cells were used for
flow cytometric analysis. In some experiments, 400 mg of anti–CD8
mAb (2.43, rat IgG2b), 400 mg of anti–CD4 mAb (GK1.5, rat
IgG2b) or isotype control rat IgG was administered to IL-15 Tg
mice 2 d before an i.p. challenge with S. choleraesuis (2 3 106 CFU).
T Helper 1 Response to Salmonella Antigen.  CD41  or CD81  T
cells purified by MACS (Miltenyi Biotechnology) in LN from Sal-
monella-infected IL-15 Tg mice or control mice on day 7 were cul-
tured with HKS in the presence of syngeneic naive mytomycin C
(MMC)-treated splenocytes for 72 h, and supernatants were exam-
ined for the following cytokine. The purity of CD41 or CD81 T
cells was confirmed to be more than 98% by FACS® analysis. 
Statistical Analysis.  The statistical significance of the data was
determined by Student’s t test. P , 0.05 was taken as significant.
Results
Generation of Two Groups of IL-15 Tg Mice.  Full-length
cDNA encoding murine IL-15 gene with the originally
described exon 5 or alternative exon 5 was inserted into a
transgenic cassette that contained the H-2K promoter, Ig
enhancer, and b-globin splice site and polyA signal (Fig. 1).
The resulting IL-15 transgenic constructs were injected
into C57BL/6 blastocysts. Three and two founders from
113 and 81 independent mice of each group were found to
be incorporated with the IL-15 transgene with the origi-
nally described exon 5 (normal IL-15 Tg mice) or alterna-
tive exon 5 (alternative IL-15 Tg mice), respectively. Ho-
mozygous transgenic mice were generated by breeding
heterozygous littermates to obtain maximal levels of IL-15
mRNA expression. All lines of each transgenic group were
born healthy and survived normally up to 12 mo. As the
analysis of offsprings of each of the three normal and two
alternative IL-15 transgenic lines showed very similar results
in each group, we demonstrate the representative results
obtained with offsprings from normal IL-15 transgenic line
3.2 and alternative IL-15 transgenic line 1.2, which contain
z10 and 2 copies of the transgene, respectively.
RT-PCR was used to estimate the mRNA expression
derived from the transgene in macrophages of IL-15 Tg
mice because the molecular sizes of these isoforms are too160 Differential Roles of IL-15 mRNA Isoforms in Immune Responses
close to separate each isoform by Northern blot analysis.
First, we examined the expression of the total IL-15 mRNA
by competitive RT-PCR using specific primers for exons 6
and 8. As shown in Fig. 2 A, the expression level of IL-15
mRNA in the peritoneal macrophages of normal IL-15 Tg
mice was eightfold higher than that of C57BL/6 control
mice, while the expression level of IL-15 mRNA in alter-
native IL-15 Tg mice was very similar to that in control
Figure 1. Schematic illustration of
the organization of the mouse IL-15
gene and IL-15 transgenes. Exons 1–8
are shown as open boxes and introns
as disconnected lines in the mouse
IL-15 gene organization above the
schematic representation of the trans-
gene construct. f denotes an alter-
natively spliced additional sequence
of exon 5. The H-2K promoter,
b-globin splice site 1 poly A signal,
and Ig enhancer are shown in the
transgenic vector. Coding regions
are indicated by black boxes and
noncoding region by stippled boxes.
Figure 2. Expression of the transgenes in the IL-15 Tg
mice. (A) Quantitative RT-PCR analysis of IL-15 Tg
mice (left). mRNA from macrophages of normal IL-15
Tg mice, alternative IL-15 Tg mice, and control C57BL/6
mice was transcribed into cDNA and amplified by PCR
using common primers for exons 6–7, and 8. cDNA
were adjusted to identical concentrations of b-actin
cDNA by coamplification of constant amounts of cDNA
and twofold dilutions of mimic. Identical amounts of
cDNA were used for PCR with IL-15–specific primer in
the presence of twofold dilution of mimic. Arrows indi-
cate the titration point when equal band intensities were
obtained for target cDNA and mimic. Southern blot
analysis of RT-PCR products amplified with primers for
exons 1 and 8 (right). The cDNA was amplified by PCR
using primers for exons 1 and 8. The PCR products were
hybridized with an internal probe specific for exon 7 or
additional sequence f. (B) Production of IL-15 protein
in the serum of IL-15 Tg mice. The serum was collected
from normal IL-15 Tg mice, alternative IL-15 Tg mice, and control C57BL/6 mice noninfected or i.p. infected with Salmonella choleraesuis (2 3 106 CFU) on
day 6, and the IL-15 protein levels were determined by mouse IL-15 ELISA. The production level of IL-15 protein was expressed as net OD absorbance at
450 nm. The IL-15 level at the line in the figure was shown as the amount of the detection limit. Data were obtained from three independent experiments and
expressed as the means of triplicate determinations 6 SD. (C) Intracellular IL-15 expression in IL-15 Tg mice. Macrophages from the peritoneum of normal
IL-15 Tg mice (a), alternative IL-15 Tg mice (b), and control C57BL/6 mice (c) were stained with anti–mouse IL-15 antibody as described in Materials and
Methods. The data are representative of three independent experiments, and typical confocal microscopic images are shown.161 Nishimura et al.
mice. We next amplified the same cDNAs from the perito-
neal macrophages by RT-PCR with specific primers for
exons 1 and 8 in the untranslated region of the IL-15 gene,
and the amplified products were hybridized with an inter-
nal common probe for both isoforms, or a specific probe
for the isoform with alternative exon 5. No alternative exon
5 was expressed in control mice and normal IL-15 transgenic
mice, whereas the expression of mRNA containing alterna-
tive exon 5 was detected in alternative IL-15 Tg mice.
We next examined the IL-15 protein levels in serum
from IL-15 Tg mice. Since recombinant murine IL-15 was
not available, we expressed net OD for the IL-15 level in
the serum. As shown in Fig. 2 B, a significant level of the
IL-15 protein was constitutively detected in the serum of
normal IL-15 Tg mice, whereas it was only at the back-
ground level in the serum from alternative IL-15 Tg or con-
trol C57BL/6 mice. We have previously reported that IL-15
production was induced in vivo by infection with Salmonella
choleraesuis 31N-1 (19). Therefore, we further examined se-
rum IL-15 levels on day 6 after Salmonella choleraesuis infec-
tion. IL-15 protein levels in the serum from normal IL-15
Tg mice and control C57BL/6 mice were upregulated after
infection, whereas serum IL-15 protein was not detected in
alternative IL-15 Tg mice after the infection. We have pre-
viously reported that the translational efficiency of the IL-15
mRNA isoform with the alternative exon 5 was significantly
higher than that of the IL-15 mRNA isoform with the nor-
mal exon 5 (34). However, the signal peptide encoded by
alternative exon 5 lacks hydrophobic domains, suggesting that
the isoform of the IL-15 protein precursor is restricted intra-
cellularly. Therefore, we examined the intracellular expression
of the IL-15 protein in the macrophages of IL-15 transgenic
mice as assessed by confocal laser microscopy with poly-
clonal anti–IL-15 Ab. As shown in Fig. 2 C, a large amount
of intracellular IL-15 protein was detected in the macro-
phages from alternative IL-15 Tg mice, but not in those from
normal IL-15 Tg or control C57BL/6 mice. Thus, consistent
with our earlier finding in vitro, the IL-15 protein is effec-
tively synthesized by alternative IL-15 transgene, but may be
restricted intracellularly. Our findings also suggest that endog-
enous IL-15 production by Salmonella infection may be sup-
pressed in the alternative IL-15 Tg mice.
Lymphocyte Development in the Thymus and Periphery of
IL-15 Tg Mice.  To investigate T cell development in the
IL-15 Tg mice, thymocytes and peripheral T cells from Tg
or wild-type animals were analyzed by flow cytometry us-
ing antibodies specific for a variety of developmentally reg-
ulated T cell surface antigens. Thymi from newborn to
4-wk-old normal IL-15 Tg mice possessed an z25% higher
level of cells than did control mice, whereas the level in
thymi from alternative IL-15 Tg mice was very similar to
that from control C57BL/6 mice. The thymi from both
IL-15 Tg mice contained normal proportions of double
negative CD42CD82, double positive CD41CD81, and
single positive CD41 or CD81 cells. Levels of CD3 and
TCR-a/b expression were also indistinguishable among
wild-type and both IL-15 Tg mice, as were the expression
levels of TCR-g/d and heat-stable antigen (data not shown).
Thus, overexpression of the normal or alternative IL-15 trans-
gene did not appear to perturb thymocyte ontogeny. The
populations of CD441CD81 T cells in the spleen and the
lymph node were threefold higher in normal IL-15 Tg mice
(Table I and Fig. 3). The CD441CD81 T cells showed a
memory phenotype such as CD252, CD692, Ly-6C1,
CD62L1, and CD45 RB1 (Fig. 4, A and B). The expres-
sion of IL-2Ra (CD25) was undetectable on CD441CD81
T cells, but IL-2/IL-15R b and g chains were highly ex-
pressed on memory-phenotype CD441CD81 T cells. On the
other hand, the proportion of memory-type CD81 T cells in
alternative IL-15 Tg mice was very similar to that in control
mice. However, it should be noted that NK1.11 cells in the
spleen of alternative IL-15 Tg mice were significantly re-
duced in number compared with control mice (Fig. 3).
Stimulation of LN Cells from IL-15 Tg Mice by IL-2/IL-15.
Our results suggest that the number of CD441CD81 T cells
constitutively expressing an IL-2/IL-15R b chain is in-
Table I. Proportion and Absolute Number of T Cell Subsets in the Lymph Node or the Spleen of Transgenic Mice Expressing Different
IL-15 Isoforms
Lymph node Spleen
Total
leukocyte
number
(3 106)
In CD31 In Leukocytes Total
leukocyte
number
(3 108)
In Leukocytes
CD41 cells CD81 cells
CD441
CD41 Cells
CD441
CD81 Cells
NK1.11
CD31 cells
NK1.11
CD32 cells
%%%% % %
Non-Tg 7.3 6 3.2* 58.2 6 11.5 33.6 6 5.5 4.0 6 1.9 3.3 6 3.7 1.2 6 0.1 3.1 6 0.4 3.1 6 0.1
Alternative IL-15 Tg 5.3 6 3.0 56.4 6 8.5 32.9 6 5.3 3.2 6 1.0 3.2 6 0.3 1.7 6 0.2‡ 1.4 6 0.7‡ 2.1 6 0.4§
Normal IL-15 Tg 7.7 6 5.5 43.0 6 8.6‡ 45.3 6 5.1‡ 5.4 6 2.4 8.8 6 3.6i 2.0 6 0.1§ 2.8 6 0.1 4.2 6 2.2
*Values represent means and SEM of three to nine individual determinations.
iP , 0.05 by Student’s t test compared with the values of non-Tg mice.
‡P , 0.01 by Student’s t test compared with the values of non-Tg mice.
§P , 0.001 by Student’s t test compared with the values of non-Tg mice.162 Differential Roles of IL-15 mRNA Isoforms in Immune Responses
Figure 3. Flow cytometry analysis of the peripheral T cell subsets in
IL-15 Tg mice. Lymphocytes were prepared from the LN or the spleen of
normal IL-15 Tg mice, alternative IL-15 Tg mice, and control C57BL/6
mice as described in Materials and Methods. The cells from the LN were
stained with FITC-CD3, PE-CD8a, and Cy-Chrome-CD4, and then the
cells were analyzed by a flow cytometer and the analysis gate was set on
CD31 cells. The cells were also stained FITC-CD44 and PE-CD8a. Cells
from the spleen were stained with FITC-CD3e and PE-NK1.1 or FITC-
CD44 and PE-CD8a, and then they were analyzed by a flow cytometer.
Data are representative of three independent experiments using pooled cells
from three mice and are shown as typical two-color profiles.
creased in normal IL-15 Tg mice. We next examined the
effect of IL-2 or IL-15 on the expansion of CD441CD81
T cells from normal IL-15 Tg mice. The LN cells from
normal IL-15 Tg or control mice were cultured with hu-
man recombinant (r) IL-2 (100 ng/ml) or IL-15 (100 ng/
ml) for 48 h, and then the blastoid cells were analyzed by
FSC (forward scatter, cell size) and SSC (side scatter, gran-
ularity) on flow cytometer. As shown in Fig. 5 A, rIL-15
and rIL-2 significantly increased the proportion of large,
blastoid cells after 48 h of culture of LN cells from normal
IL-15 Tg mice. We stained the responding cells, as evidenced
by their blastoid appearances to rIL-15 or rIL-2 with anti–
CD44 and –CD8 mAbs. Flow cytometric analysis revealed
that the blastoid cells after culture with rIL-15 represented
CD441CD81 T cells, indicating that CD441CD81 T cells
proliferated in response to rIL-15 as well as to rIL-2. The
ability of the lymph node cells in normal IL-15 Tg mice to
respond to rIL-15 or rIL-2 was significantly higher than
that in alternative IL-15 Tg mice. The CD441CD81 T cells
in Fig. 5 A were nonaddition, 25.5 6 5.5 vs. 28.3 6 11.0%;
IL-2, 70.2 6 3.8 vs. 53.3 6 8.2%; IL-15, 71.0 6 4.2 vs.
40.2 6 5.3% (IL-15 transgenic mice versus control mice).
On the other hand, the ability of the LN cells of alternative
IL-15 Tg mice to respond to these cytokines was not dif-
ferent from that of control mice (data not shown).
To assess whether cell proliferation by IL-2 or IL-15 in-
duces cytokine production, we examined cytokine produc-
tion in the culture supernatant of lymphocytes from IL-15
Tg mice or control mice. As shown in Fig. 5 B, LN cells
from normal IL-15 Tg mice produced a larger amount of
IFN-g in response to IL-2 or IL-15, while those from non-
Tg or alternative IL-15 Tg mice produced only a marginal
level of IFN-g in response to IL-2 or IL-15. Other cyto-
kines, including IL-4, IL-10, TNF-a, and IL-13, were not
detected in any culture supernatants. These results suggest
that memory-phenotype CD441CD81 T cells in the nor-
mal IL-15 Tg mice can expand and produce IFN-g in re-
sponse to bystander stimulation with IL-2 or IL-15.
Cytokine Production by LN Cells in IL-15 Transgenic Mice
upon TCR Triggering. Memory-type T cells are character-
ized by early cytokine production upon TCR engagement
(41, 42). Therefore, we examined the cytokine production
of LN cells from IL-15 Tg mice or control mice in re-
sponse to immobilized anti–TCRab mAb. IFN-g was rap-
idly produced by LN cells in normal IL-15 Tg mice within
24 h after stimulation with immobilized anti–TCR anti-
bodies, while LN cells from alternative IL-15 Tg mice pro-
duced only a marginal level of IFN-g, if any, after stimula-
tion (Fig. 6). To confirm that early IFN-g production depends
on memory-type CD81 T cells in normal IL-15 Tg mice,
we next examined the cytokine production of T cells in
IL-15 Tg mice after in vivo administration of anti–TCR
mAb. As shown in Fig. 7, IFN-g–producing cells were ob-
served in populations of CD81CD441 cells, but not in
those of CD442 cells. In correlation with the number of
memory-type CD81 T cells, the number of IFN-g–pro-
ducing cells in normal IL-15 Tg mice was larger than that
in control mice, while the number of IFN-g–producing cells
in alternative IL-15 Tg mice was greatly reduced compared
with that in control mice.
Susceptibility to Salmonella Infection in IL-15 Tg Mice. To
investigate whether protective immunity against bacteria is
affected in normal IL-15 or alternative IL-15 Tg mice, these
mice were intraperitoneally injected with a sublethal dose
of Salmonella choleraesuis. The growth kinetics of S. cholerae-
suis in the peritoneum were monitored for 6 d after an i.p.
challenge with S. choleraesuis. As shown in Fig. 8 A, the num-
ber of bacteria in the peritoneal cavity of normal IL-15 Tg
mice was significantly smaller than that in control mice
on days 3 and 6 (P , 0.05). On the other hand, alternative
IL-15 Tg mice had increased numbers of Salmonella as
compared with control mice. In correlation with the pro-
tection level as assessed by bacterial growth, the level of
IFN-g in the serum of normal IL-15 Tg mice was signifi-
cantly higher than that in control mice on day 6 after an163 Nishimura et al.
i.p. challenge with S. choleraesuis (P , 0.001), while the
IFN-g level in the serum of alternative IL-15 Tg mice was
lower than that in control mice (Fig. 8 B). IL-4 was not de-
tected in the serum at any stage during salmonellosis. We
next compared the cellular response in the peritoneum be-
tween IL-15 Tg and control mice during Salmonella infec-
tion. The absolute number of peritoneal nonadherent cells
in normal IL-15 Tg mice (1.2 6 0.2 3 107 cells/mouse)
was larger than that in control mice (4.8 6 0.1 3 106 cells/
mouse, P , 0.001), whereas that in alternative IL-15 Tg
mice was not different from those in control mice. A typi-
cal two-color profile is shown in Fig. 9. The CD81 T cells
in the peritoneal cavity of normal IL-15 Tg mice were
markedly increased on day 6 after the i.p. challenge with S.
choleraesuis compared with that in alternative IL-15 Tg
and control mice. The numbers of NK1.11CD32 cells and
NK1.11CD31 cells were also significantly increased in the
peritoneal cavity of normal IL-15 Tg mice on day 6 after
infection with Salmonella compared with that in control
mice, while the number of NK1.11CD32 cells were signif-
icantly reduced in alternative IL-15 Tg mice after Salmo-
nella infection.
Early IFN-g production plays an important role not only
in host defense at the early stage, but also in determining
differentiation of naive CD41 T cells to Th1 cells during
infection with Salmonella species. Therefore, we next com-
pared the generation of CD41 Th1 cells specific for Salmo-
nella in normal and alternative IL-15 Tg mice. As shown in
Fig. 10, CD41 T cells from normal IL-15 Tg mice on day 6
after the i.p. challenge with S. choleraesuis produced a larger
amount of IFN-g in response to HKS than did those from
control mice, while CD41 T cells in the LN of alternative
IL-15 Tg mice produced a smaller amount of IFN-g than
did those in control mice. CD81 T cells from normal IL-15
Tg mice or control mice produced only a small amount of
IFN-g in response to HKS. On the other hand, no IFN-g
production was evident in the CD81 T cells from alterna-
tive IL-15 Tg mice on day 6 after infection with S. cholerae-
suis. These results suggest that Th1 cells are efficiently gen-
erated in normal IL-15 Tg mice but poorly generated in
alternative IL-15 Tg mice.
Effect of CD81 or CD41 T Cell–depletion on Protection
Against Salmonella Infection in the Normal IL-15 Transgenic
Mice.  Our results raise the possibility that the increase in
the number of memory-phenotype CD81 T cells in the
normal IL-15 Tg mice augmented the protective immunity
against Salmonella infection. To address the potential role of
CD81 or CD41 T cells in normal IL-15 Tg mice, we ex-
amined the effect of in vivo administration of anti–CD8 or
–CD4 mAb to deplete CD81 or CD41 T cells on the sus-
ceptibility to S. choleraesuis in the normal IL-15 Tg mice.
The normal IL-15 Tg mice were injected intraperitoneally
with anti–CD8 or –CD4 mAb 2 d before a Salmonella chal-
lenge. We confirmed by FACS® analysis that CD81 or
CD41 T cells were almost completely depleted in the peri-
toneum and the LN 6 d after the i. p. challenge with S. chol-
eraesuis (data not shown). As shown in Fig. 11 A, the num-
ber of bacteria was significantly increased in the peritoneal
cavity of normal IL-15 Tg mice depleted of CD81 and
CD41 T cells compared with that in mice treated with iso-
type control rat IgG (P , 0.001). Thus, CD81 and CD41
T cells serve to protect against Salmonella infection in nor-
mal IL-15 Tg mice. We further examined the effect of
CD8 cell depletion on the generation of CD4 Th1 cell re-
sponse in normal IL-15 Tg mice after Salmonella infection.
The CD41 T cells were harvested on day 6 after Salmo-
nella infection and stimulated in vitro in the presence of
HKS and APC. The CD41 T cells from anti–CD8 mAb-
treated normal IL-15 Tg mice showed a significantly
decreased production of IFN-g in response to heat-killed
Salmonella compared with those from isotype control IgG-
treated mice (Fig. 11 B). CD81 T cells from anti–CD4 mAb
or control rat IgG-treated normal IL-15 Tg mice produced
only a marginal level of IFN-g in response to HKS. These
Figure 4. Cell surface markers on CD441CD81 T cells in normal IL-15 Tg mice. (A) Ex-
pression of activation markers on the CD81 T cells from the LN of normal IL-15 Tg mice
was examined by a flow cytometer. The cells were stained with FITC-CD44, Biotin-
CD8a, and PE-mAbs against various markers, and then they were analyzed by a flow cy-
tometer, and the analysis gate was set on CD81 cells. Data are representative of three inde-
pendent experiments using pooled cells from three mice and are shown as typical two-color
profiles. (B) Expression of IL-2 receptor subunits on CD81 or CD41 T cells from the LN of
normal IL-15 Tg mice were examined. The cells were stained with PE-CD44, Cy-
Chrome–CD4, or biotin-CD8a, and FITC-mAbs against IL-2 receptor subunits, and they
were then analyzed by a flow cytometer, and the analysis gate was set on CD441 or CD442
on CD41 or CD81 cells. Data are representative of three independent experiments using
pooled cells from three mice and are shown as typical single-color profiles.164 Differential Roles of IL-15 mRNA Isoforms in Immune Responses
results suggest that the CD81 T cells may be at least partially
responsible for the augmented Th1 response in normal IL-15
Tg mice infected with Salmonella.
Discussion
In the present study, we generated two types of IL-15
Tg mice: normal IL-15 Tg mice expressing IL-15 cDNA
with the originally described exon 5 and alternative IL-15
Tg mice expressing a novel IL-15 cDNA with an alterna-
tive exon 5. We found that the number of memory-pheno-
type CD81 T cells increased significantly in normal IL-15
Tg mice that constitutively produced a significant level of
IL-15 in the serum. The CD81 cells were stimulated to
produce IFN-g by exogenous IL-2/IL-15 in a bystander
manner. The normal IL-15 Tg mice showed resistance to
an i.p. infection with a virulent strain of Salmonella cholerae-
suis accompanied by increases in memory-type CD81 T
cells and CD4 Th1 cells specific for Salmonella. These re-
sults suggest that overexpression of the normal IL-15 trans-
gene may induce expansion of memory-type CD81 T cells,
which serve to enhance the protective immunity against
Salmonella infection through early IFN-g production and
enhanced CD4 Th1 cell response. On the other hand, T
cells from alternative IL-15 Tg mice exhibited impaired
IFN-g production upon TCR engagement, and the alter-
native IL-15 Tg mice were susceptible to an i.p. challenge
with Salmonella choleraesuis accompanied by impaired re-
leases of IL-15 and IFN-g and poor CD4 Th1 response.
The overexpression of the alternative IL-15 transgene may
negatively regulate the endogenous IL-15 production, re-
sulting in suppression of subsequent protective immunity
against Salmonella infection.
It is now widely accepted that IL-15 is important for the
maintenance of lymphocytes, especially memory-type CD81
T cells (11, 43). We showed that CD81 T cells expressing
memory markers increased in normal IL-15 Tg mice. The
memory-phenotype CD81 cells were found to express a
high level of antiapoptotic protein Bcl-2, but not proapop-
tosis protein BAX (data not shown). This indicates that the
memory phenotype CD81 T cells are maintained by over-
expression of IL-15 through upregulation of an antiapop-
totic protein such as Bcl-2 or Bcl-XL via the IL-2/IL-15R
b chain. It is notable that normal IL-15 Tg mice were resis-
tant to infection with a virulent strain of S. choleraesuis. We
have previously reported that NK cells serve to protect
against infection with avirulent S. choleraesuis (44). In the
present study, besides NK cells, CD81 T cells were remark-
ably increased in normal IL-15 Tg mice compared with
those in control mice after Salmonella infection and, concur-
rently, IFN-g production in the serum was augmented during
the infection. Experiments with in vivo depletion of CD81
T cells revealed that CD81 T cells contribute to the resolu-
tion of Salmonella infection in normal IL-15 Tg mice. There
are several possible explanations of how the CD81 T cells
serve to protect against Salmonella infection in normal IL-15
Tg mice. First, the memory CD81 T cells may recognize
the conserved antigens in Salmonella, which are common to
Figure 5. Bystander activation of CD441CD81 T cells in IL-15 Tg
mice. (A) Flow cytometry analysis of LN cells from normal IL-15 Tg
mice or control C57BL/6 mice after culture with rIL-2 or rIL-15 was
performed. The LN cells were cultured with or without rIL-2 (100 ng/ml)
or rIL-15 (100 ng/ml) for 48 h at 378C. After the culture, the cells were
stained with PE-CD8a and FITC-CD44 mAb, and they were then ana-
lyzed by a flow cytometer. Blastoid cells were gated in FSC and SSC pro-
files as R1. CD44 expression on the responding cells, as evidenced by
their blastoid appearance to rIL-15 or rIL-2, was presented as typical two-
dimensional profiles. (B) Cytokine production of the LN cells in response
to rIL-2 or IL-15 in IL-15 Tg mice was assessed by ELISA. The culture
supernatant of A was collected and the IFN-g activity was determined.
The data are representative of two separate experiments and are expressed
as the mean of triplicates 6 SD.165 Nishimura et al.
previously encountered Ag such as environmental Ag or
self antigens. However, Vb repertoires of the CD81 T cells
are diversified and not skewed (data not shown). Further-
more, CD81 T cells in normal IL-15 Tg mice infected with
Salmonella are not specialized to recognize heat-killed Sal-
monella. Therefore, it is unlikely that the memory T cells
cross-react with a conserved Ag in Salmonella. There are
several lines of evidence for the strong bystander stimula-
tion of CD81 T cells in vivo elicited by various infectious
agents (45–52). Lymphocytic choriomeningitis virus infec-
tion induces activation and expansion of CD81 T cells.
Limiting dilution analysis to quantitate virus-specific cyto-
toxic T lymphocytes has shown that only a small fraction
(1–5% at most) of the activated CD81 T cells are antigen
specific at the peak of the primary response (45–47). Thus,
memory-phenotype CD81 T cells are subject to nonantigen-
specific “bystander” stimulation through contact with vari-
ous cytokines released during infection with pathogens.
Zhang et al. (43) have reported that the strong bystander
stimulation of CD81 T cells in vivo elicited by various in-
fectious agents is driven by IFN I–induced production of
IL-15. We showed direct evidence for bystander stimula-
tion of CD441CD81 T cells from IL-15 transgenic mice by
exogenous IL-2 or IL-15. Therefore, it is most likely that
most of the CD81 T cells expand in a bystander manner by
endogenous IL-2 and/or IL-15 produced during Salmonella
infection. Salmonella serovars are facultative parasites that
are capable of surviving and persisting within mammalian
host cells, and Th1-type response is essential for control of
such intracellular pathogens (44, 53, 54). The normal IL-15
Tg mice appeared to generate CD4 Th1 cells more effi-
ciently than did control mice after Salmonella infection.
Early IFN-g production is thought to be important for in-
duction of Th1 response mediated by ab T cells (55, 56).
Our present results revealed that CD41 T cells play a po-
tential role in protection against Salmonella infection in
normal IL-15 Tg mice and that CD41 T cells from anti–
CD8 mAb-treated normal IL-15 Tg mice showed a signifi-
cantly decreased production of IFN-g in response to HKS.
Hence, early IFN-g produced by CD81 T cells may serve
to induce a Th1 response by ab T cells against S. cholerae-
suis 31N-1. However, in vivo depletion of CD81 T cells
only partially inhibited CD41 Th1 cell development in nor-
Figure 6. IFN-g production of
LN cells in IL-15 Tg mice in re-
sponse to TCR triggering. The LN
cells from normal and alternative IL-
15 Tg mice and control C57BL/6
were cultured in the presence
(closed bars) or absence (open bars)
of immobilized anti–TCR a/b
mAb. At 24, 48, or 72 h after incu-
bation, culture supernatants were
harvested, and IFN-g was measured
by ELISA. The proliferation activity
was assessed by incorporation of 3H-
thymidine. The data are representa-
tive of three independent experi-
ments using pooled cells from three
transgenic mice or control mice and
are shown as the mean of triplicate
determinations 6 SD.
Figure 7. Expression of IFN-g in CD441CD81 T cells after an i.v. in-
jection of anti–CD3 mAb. Normal or alternative IL-15 Tg mice or con-
trol C57BL/6 mice were injected intravenously with 4 mg of anti–CD3
mAb (145-2C11). After 90 min, spleen cells were harvested and cultured
for 3 h at 378C in the presence of 10 mg/ml Brefeldin A. Intracellular cy-
tokine-producing cells were examined by flow cytometry and analyzed
by gating on CD81 T cells. Data are representative of three independent
experiments using pooled cells from three mice and are shown as typical
two-color profiles.166 Differential Roles of IL-15 mRNA Isoforms in Immune Responses
mal IL-15 Tg mice after Salmonella infection. Besides
CD81 T cells, NK cells are significantly increased in nor-
mal IL-15 Tg mice after Salmonella infection. Therefore,
not only CD81 cells, but also NK cells may be responsible
for early IFN-g production, and in turn induction of CD41
Th1 development in these mice. It thus appears that IL-15
may serve to protect against microbial infection through
not only activation of innate immunity, but also induction
of adaptive immunity.
Another notable finding in the present study is that alter-
native IL-15 Tg mice are susceptible to a virulent Salmo-
nella infection accompanied by impaired releases of IL-15
and IFN-g and poor responses of NK cells and CD4 Th1
cells. We also showed that early cytokine production by in
vivo administration of anti–CD3 mAb was severely impaired
in the Tg mice. The IL-15 protein is thought to be post-
transcriptionally regulated by multiple control elements that
impede translation, including upstream AUGs of 59UTR,
unusual signal peptides, and the COOH terminus of the
mature protein (5, 34–38). We could not detect IL-15 in the
serum of alternative IL-15 transgenic mice infected with
S. choleraesuis, although these cells expressed an abundant
level of intracellular IL-15. The alternative splicing path-
way represents a mechanism whereby diversity is generated
in a reversible fashion without a requirement for the ex-
pression of new genes (57–59). Changes in the alternative
splicing of specific pre–mRNA molecules may be associated
with a unique function of each isoform. Our results suggest
that overexpression of the intracellular IL-15 isoform may
suppress the endogenous IL-15 production. Abnormalities
of IL-15 have been reported in inflammatory disorders of
autoimmune diseases such as rheumatoid arthritis or inflam-
Figure 8. Susceptibility to Salmonella infection in IL-15 transgenic
mice. (A) Bacterial growth of S. choleraesuis in the peritoneal cavity after
an i.p. challenge with S. choleraesuis. Mice were injected intraperitoneally
with 2 3 106 CFU. The number of bacteria was determined by a colony
formation assay in tripto-soya agar plates. Data were obtained from three
separate experiments and are expressed as the mean 6 SD for nine mice at
each point. Statistically significant differences between Tg mice and con-
trol mice are shown (*P , 0.05, **P , 0.001). (B) IFN-g production in
the serum of IL-15 transgenic mice after infection with S. choleraesuis. Se-
rum was collected from normal or alternative IL-15 Tg mice or control
mice after an intraperitoneal challenge with S. choleraesuis. The amount of
IFN-g in the serum was determined by ELISA. Data were obtained from
three separate experiments and are expressed as the mean 6 SD for nine
mice at each point. Statistically significant differences between transgenic
mice and control mice are shown (*P , 0.001).
Figure 9. Flow cytometry analysis of the peritoneal exudate cells in
IL-15 Tg mice infected with S. choleraesuis on day 6. Nonadherent perito-
neal exudate cells of normal and alternative IL-15 Tg mice and control
C57BL/6 mice were stained with FITC-CD3, PE-CD8a, and Cy-
chrom-CD4, and then the cells were analyzed by a flow cytometer and
the analysis gate was set on CD31 cells. The cells were also stained FITC-
CD3e and PE-TCR-g/d or -NK1.1. Data are representative of three in-
dependent experiments using pooled cells from three mice and are shown
as typical two-color profiles.167 Nishimura et al.
matory bowel disease (28–31). The broad constitutive ex-
pression of the IL-15 gene in several normal tissues suggests
that mechanisms controlling protein synthesis of secretion
must operate in these cells to prevent an inappropriate acti-
vation of the immune system. Thus, it is possible that the in-
tracellular IL-15 isoform plays the role of negative feedback
on the endogenous IL-15 production to prevent excessive
immune responses. The mechanism whereby intracellular
IL-15 isoform suppresses endogenous IL-15 production is
not known. Tagaya et al. (37) have reported that a part of
the intracellular isoform of IL-15 is located in the nucleus,
although the intracellular IL-15 isoform lacks a nuclear lo-
calization signal. Interestingly, IL-15Ra, the specific bind-
ing subunit of the T/NK type I IL-15 receptor, possesses a
potential nuclear localization signal in its signal peptide, in-
dicating that the intracellular IL-15 isoform may be colo-
calized in the nucleus with IL-15Ra. Taken together, we
presume that intracellular IL-15/IL-15Ra complex may
affect transcription of endogenous IL-15 gene. But this is
only speculation, further analysis of the impediment mech-
anism on the IL-15 gene expression by the intracellular iso-
form of IL-15 is required.
In conclusion, we found that the number of memory-
phenotype CD81 T cells increased significantly in normal
IL-15 Tg mice. They rapidly expanded and produced IFN-g
in response to IL-2/15Rb-dependent cytokines. After an
intraperitoneal challenge with S. choleraesuis, CD81 T cells
markedly expanded in the peritoneum of normal IL-15 Tg
mice at the early stage of infection accompanied by in-
creased IFN-g production and protected against infection.
On the other hand, we found that the expression of endog-
enous IL-15 mRNA with the original exon 5 was suppressed
in the alternative IL-15 Tg mice. The alternative IL-15 Tg
mice were highly susceptible to an i.p. challenge with S. cho-
leraesuis accompanied by a lower level of IFN-g in the serum.
Analysis of two groups of IL-15 Tg mice may provide in-
formation concerning the differential roles of IL-15 iso-
forms in the immune system in vivo.
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Figure 10. Generation of CD4 Th1 cells specific for Salmonella antigen
in IL-15 Tg mice. CD41 T cells (2 3 105 cells) or CD81 T cells (2 3 105
cells) in LN of IL-15 Tg mice or control mice on day 6 after an i.p. chal-
lenge with S. choleraesuis (2 3 106 CFU) were purified by MACS and cul-
tured with or without heat-killed Salmonella in the presence of MMC-
treated splenocytes (106 cells) for 3 d at 378C. Thereafter, the supernatants
were collected and cytokine activity was determined by ELISA. The data
are representative of three independent experiments using pooled cells
from five IL-15 Tg or control mice and shown as the mean of triplicate
determinations 6 SD. Statistical analysis was performed by means of Stu-
dent’s t test. Significant differences compared with the values in control
mice are shown: *P , 0.01.
Figure 11. Effect of in vivo CD8
or CD4 depletion on Th1 response in
normal IL-15 Tg mice. (A) Bacterial
growth of S. choleraesuis in the spleen
or the liver of CD8- or CD4-depleted
normal IL-15 Tg mice on day 6 after
an i.p. challenge with S. choleraesuis.
Anti–CD8 mAb (400 mg, rat IgG2b,
2.43), anti–CD4 mAb (400 mg, rat
IgG2b), or isotype control rat IgG was
administered to normal IL-15 trans-
genic mice 2 d before an i.p. challenge
with  S. choleraesuis (2 3 106 CFU).
The number of bacteria was deter-
mined by colony formation assay in
tripto-soya agar plates. Data are ob-
tained from three separate experi-
ments and are expressed as the mean 6
SD for four mice at each point. Statistical analysis was performed by means of Student’s t test. Significant differences compared with the values in control
IgG-treated mice are shown: *P , 0.001. (B) CD41 T cells (2 3 105 cells) or CD81 T cells (2 3 105 cells) in LN of normal IL-15 Tg mice depleted
CD8, CD4, or nondepleted on day 6 after an i.p. challenge with S. choleraesuis (2 3 106 CFU) were purified by MACS and cultured with or without
heat-killed Salmonella in the presence of MMC-treated splenocytes (106 cells) for 3 d at 378C. Thereafter, the supernatants were collected, and cytokine
activity was determined by ELISA. The data are representative of three independent experiments using pooled cells from five normal IL-15 Tg or control
mice and shown as the mean of triplicate determinations 6 SD. Statistical analysis was performed by means of Student’s t test. Significant differences
compared with the values in control-IgG treated mice are shown: *P , 0.01.168 Differential Roles of IL-15 mRNA Isoforms in Immune Responses
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